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Abstract
Background: Many previous studies have suggested that the number of lymph nodes retrieved should
serve as a benchmark for assessing the adequacy of the resection. The aim was to retrospectively
observe the impact of nodal retrieval after educating the pathologist.
Methods: Patients undergoing a pancreaticoduodenectomy (PD) between September 2005 and March
2009 were included in the study. The PDs performed between September 2005 and March 2008 were
designated as Group A. The pathologists were educated regarding the importance of nodal counts in PD
by the surgeon on the 1st April 2008. PDs performed between April 2008 and March 2009 were
designated as Group B.
Results: Ninety-eight PDs performed by a single surgeon (D.R.J.) for peri-ampullary malignancy were
evaluated. The median number of lymph nodes retrieved in Group A was 11(3–32) nodes. The median
number of lymph nodes retrieved in Group B was 22 (10–29) nodes (P < 0.001).The lymph node ratio
(positive/total nodes), median number of positive nodes retrieved, and the node positivity (node positive
compared to node negative) rate did not change.
Discussion: A single intervention with the pathologists did impact the number of lymph nodes retrieved
from PD specimens. However, the lymph node ratio and lymph node positivity rate remained unchanged.
The pathologist is critical to nodal retrieval in PD, but the use of this lymph node number for benchmark
of surgical adequacy may be simplistic.
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Introduction
Peri-ampullary malignancies include tumours of the distal bile
duct, duodenum, pancreatic head and ampulla. Whenever possi-
ble, they are best treated by a pancreaticoduodenectomy (PD).
Lymph node positivity (patients with any nodes positive) has an
impact on the prognosis of peri-ampullary cancers, especially
pancreatic cancer.1–4 The role of an extended lymphadenectomy
on the long-term survival of patients with pancreatic cancer after
a PD has been extensively debated.5–8 Most studies have shown no
survival benefit with an extended lymphadenectomy and an
increase in post-operative morbidity.6 The utility of a generous
nodal retrieval in local control is an issue that has not been clearly
documented. The lymph node ratio (LNR) is an important factor
and is calculated by dividing the total number of positive nodes in
node positive patients by the total number of nodes retrieved.
Recent data suggest that the ratio of positive lymph nodes to the
total number of examined lymph nodes, i.e. LNR, in periampul-
lary cancers is an independent prognostic factor.9–17 These data
suggest that the nodal ratio, rather than the absolute number of
involved nodes, may indeed be the most important prognostic
factor for tumours in various sites.18–23 However, other studies
have cited that the number of lymph nodes retrieved from a PD
specimen should serve as a quality measure in the treatment of
pancreatic adenocarcinoma.24,25 In fact, several experts in the field
have suggested that there should be a minimum number of nodes
to adequately stage pancreatic malignancies. Breast cancer treat-
ment protocols use nodal retrieval as a benchmark for the
adequacy of an axillary dissection.26 Nevertheless, the lymph node
yield (LNY) is a variable which can be impacted by several factors.
These factors include anatomical factors (i.e. factors related to the
individual patient), the technical aspects of the procedure (for
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example, a pylorus-preserving PD compared with a standard PD),
surgeon-related factors (for example, years of experience) and
factors related to the pathologist (for example, how the specimen
is handled).
A key objective of this study was to examine the pathologist as
a factor in lymph node retrieval. The study was performed to
assess the impact of the pathologist after a single intervention by
the surgeon, namely verbal education on the median number of
lymph nodes retrieved from PD specimens.
Methods
The records of patients who underwent PD for peri-ampullary
neoplasms between September 2005 and March 2009 were
reviewed. All the PDs were performed by a single surgeon at a
non-university tertiary care centre (NUTCC). All patients under-
went a modified extended lymphadenectomy, i.e. the vena cava
was skeletonized from the gonadal vein to gonadal vein, without
dissection of celiac or aortocaval lymph nodes. The records were
reviewed under an institutional review board-approved protocol
with respect to the number of lymph nodes retrieved, LNY, LNR
and the node positivity rate. The ratio was calculated by dividing
the positive node count by the total nodal count in those patients
that were overall node positive. The nodal positivity rate was
calculated by looking at all node positive patients compared with
all patients, node positive or negative overall. The PDs performed
between September 2005 and March 2008 were designated as
Group A. The pathologists and pathology assistants (who gross
the specimens at our institution) were educated verbally on 1
April 2008. PDs performed over the next year (April 2008 to
March 2009) were designated as Group B. Briefly, the pathologists
and the Physicians Assistants (PAs) – the latter gross the speci-
mens – were gathered and briefly educated on the evolving need of
nodal retrieval as a benchmark for adequate dissection in many
tumour sites. The group already used the method of Verbeke with
four colour inking of the specimen, as outlined below. The inter-
vention was purely focused on nodal retrieval, and no alterations
were made to handling the specimen with regards to margin
assessment. The pathologists were unaware of the study until its
end on 1 April 2009, allowing a comparison on lymph node yield
while keeping the other factors constant. All PD specimens were
inked using four colours and dissected by pathologists and pathol-
ogy assistants with expertise in pancreato-biliary pathology. The
peri-pancreatic and peri-gastric fat was dissected for lymph
nodes. Small nodes (size5 mm) were submitted intact, whereas
larger nodes were sectioned and totally submitted. The results
between Groups A and B were compared. Statistical analysis was
performed using the paired t-test.
Results
A total of 144 PDs were performed, 98 for peri-ampullary malig-
nancy. Sixty-three PDs were performed for peri-ampullary
cancers between September 2005 and March 2008 by a single
surgeon (Group A). Thirty-five PDs were performed for peri-
ampullary cancers between April 2008 and March 2009 (Group
B). The distribution of the peri-ampullary cancers by Tumor (T)
stage is similar between the groups (see Table 1). T4 staged
tumours consisted of duodenal and ampulla of vater primaries.
The median number of lymph nodes retrieved in Group A was 11
(range 3–32). The median number of lymph nodes retrieved in
Group B was 22 (range 10–29) (P = 0.001). There were a higher
number of nodes in retrieved node positive and node negative
disease (Table 2). The distribution of pylorus preserving and a
standard PD was not significant between the groups (Table 3).
There was an increase in LNY, post-intervention with pylorus
preserving (PPPD) and standard PD (SPD). An increase was seen
not only in the overall LNY but also in the LNY in lymph node
negative (pN0) disease. Importantly, the LNR in node positive
disease was not affected by the intervention. The percentage of
patients with node positive disease (pN1) in the Group B was the
same (66%) as those in Group A (65%) (Table 3).
Discussion
This study examines the importance of the pathologist as a factor
in lymph node retrieval from PD specimens. This is the first study
to show that a single intervention with the pathologist can result
in an increase in nodal retrieval while keeping other factors con-
stant. Importantly, the overall incidence of lymph node positivity
and LNR in node positive patients did not change in the study
period. This suggests that in spite of an increased nodal retrieval,
the LNR was not affected by the number of nodes retrieved.
The behaviour of peri-ampullary cancers after a resection is
influenced by many pathological factors which can include
tumour size, tumour type, tumour grade, margin status, lym-
phovascular invasion, perineural invasion and lymph node sta-
tus.1,2 The surgeon’s aim is to minimize the risk of under-staging
by performing an adequate lymph node clearance. An extended
lymphadenectomy, which was postulated to avoid stage migra-
tion, has not been proven to improve long-term survival.7 More
recently, there has been an effort to stratify lymph nodal positivity
into a more discerning variable. LNR has been reported as a pow-
erful predictor of survival in other gastrointestinal tumours, such
as the colon and stomach.18,19,22,23 Le Voyer et al. reported that LNR
was an important prognostic factor for colon cancer after a colec-
Table 1 Distribution of the peri-ampullary cancers as per stage for
Groups A (pre-education) and Group B (post-education)
Tumour
stage
Number (%)
of Group A
Number (%)
of Group B
Tis 2 (3) 0 (0)
T1 2 (3) 1 (3)
T2 18 (29) 8 (23)
T3 29 (46) 23 (65)
T4 12 (19) 3 (9)
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tomy even after adjusting for other factors as tumour stage, grade,
histology and the number of positive lymph nodes.22 Similarly,
LNY and LNR are increasingly being reported as prognostic
factors for peri-ampullary cancers, especially pancreatic
adenocarcinoma.18–23
The question of whether a minimum number of nodes should
be obtained to properly stage patients, has been assessed by several
investigators.27 Previous studies have also suggested that a ‘cutoff
LNY’ should be established to adequately stage pancreatic cancer.
This is similar to standards advocated for breast and colon cancer.
The minimum number of nodes suggested vary from 10,11 129,10 to
15.24,25 The investigators further suggest that these cutoff LNY may
also serve as a tool to assess the adequacy of a surgical resection
and suggest that it be regarded as a quality measure.
The LNY is dependent on many factors, as outlined above.
These include the surgical procedure (PPPD versus SPD), sur-
geons, anatomical factors and pathologists. There is disparity in
the number of nodes retrieved during a PD at different institu-
tions. Pawlik et al. reported that the median number of lymph
nodes evaluated at Johns Hopkins Hospital was 17,9 whereas in a
large population-based study, Slidell et al. found the median LNY
in the SEER dataset was 7.10 The extent of a lymph node dissection
may vary from surgeon to surgeon as does the pathologists’ tech-
nique in dissecting the specimen. The data presented here dem-
onstrates that educating the pathologists resulted in an increase in
LNY but without affecting the LNR. More nodes were dissected on
standard PD specimens; however, an increase in LNY was seen
with both SPD and PPPD post-education. The increase was seen
not only in the overall yield but also in the LNY for pN0 disease
and pN1 disease, when analysed as separate groups. However,
importantly, the percentage of pN1 patients in the post-education
group (66%) remained the same as in the pre-education group
(65%). This study clearly demonstrates that intervention resulted
only in an increase in the LNY without an upstaging of the overall
node status or change in the LNR.
This study demonstrates that continuous communication with
the pathologists is important. The pathologists and physician
assistants in this study were educated informally with these noted
results. The HPB surgeon should continuously monitor their own
nodal counts and communicate with the pathologists if they note
variation in nodal numbers.
The patients with pN0 disease in the pre-education group
would have been adequately staged if a LNY cutoff of 12, 15 or 16
nodes was assumed to be adequate. The patients in the post-
education group would now be adequately staged owing to an
‘adequate’ LNY, however, the node positivity rate remained
unchanged; in spite of the increased LNY. Moreover this did not
impact the retrieval of positive nodes. The idea of ‘look more to
find more’, which has been shown to work for margin positivity in
pancreatic cancer, did not appear to affect nodal positivity in this
study.
Lymph node retrieval after PD can increase significantly after a
single intervention with the pathologist. However, staging, as
measured by overall lymph node positivity LNR, and the number
of positive nodes retrieved, were not affected by increased nodal
retrieval. These data would suggest that adequate nodal staging
was performed even when fewer lymph nodes were retrieved by
the pathologist.
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